Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission.
van Rhenen, A
Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission. [electronic resource] - Leukemia Aug 2007 - 1700-7 p. digital
Publication Type: Comparative Study; Journal Article
0887-6924
10.1038/sj.leu.2404754 doi
ADP-ribosyl Cyclase 1--metabolism
Acute Disease
Adolescent
Adult
Aged
Antigens, CD34--metabolism
Biomarkers, Tumor--metabolism
Bone Marrow--metabolism
Female
Flow Cytometry
Hematopoietic Stem Cells--cytology
Humans
Immunophenotyping
In Situ Hybridization, Fluorescence
Leukemia, Myeloid--diagnosis
Male
Middle Aged
Neoplasm, Residual--diagnosis
Neoplastic Stem Cells--metabolism
Prognosis
Remission Induction
Risk Factors
Survival Rate
Aberrant marker expression patterns on the CD34+CD38- stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission. [electronic resource] - Leukemia Aug 2007 - 1700-7 p. digital
Publication Type: Comparative Study; Journal Article
0887-6924
10.1038/sj.leu.2404754 doi
ADP-ribosyl Cyclase 1--metabolism
Acute Disease
Adolescent
Adult
Aged
Antigens, CD34--metabolism
Biomarkers, Tumor--metabolism
Bone Marrow--metabolism
Female
Flow Cytometry
Hematopoietic Stem Cells--cytology
Humans
Immunophenotyping
In Situ Hybridization, Fluorescence
Leukemia, Myeloid--diagnosis
Male
Middle Aged
Neoplasm, Residual--diagnosis
Neoplastic Stem Cells--metabolism
Prognosis
Remission Induction
Risk Factors
Survival Rate